“APR-246 Enhances the Anticancer Effect of Doxorubicin Against p53-Mutant AsPC-1 Pancreatic Cancer Cells”. Baghdad Science Journal, vol. 21, no. 8, Aug. 2024, p. 2551, https://doi.org/10.21123/bsj.2024.10135.